FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
Recent Posts
The Innovation Voucher, offered by Business Finland, is one funding opportunity for Finnish SMEs who seek for purchasing new knowledge and skills for their business. According to Business Finland,...
Headquartered in Helsinki, Finland, MEGIN is the global leader for magnetoencephalography (MEG) technology used for their non-invasive functional brain mapping solution. A long-term collaboration...
Innokas Medical, with expertise dedicated to medical devices and software, and Biocodex PhaMe, providing pharmaceutical consultant services, have agreed on a strategic partnership. Through this...
In Finland, we celebrate our 103 years of independence today. Innokas Medical wishes everyone a happy Finnish Independence Day! đź’™ #Suomi103
Mr. Janne Kostamo (Executive MBA, M.Sc. in Industrial Eng. and B.Sc. in Mech. Eng.) has been appointed as new CEO of Innokas Medical. 50-year old Kostamo brings 18 years of experience in...
With their next-generation innovation, Synoste aims to renew surgical treatment related to bone deformities. Innokas Medical is involved in this mission by being one of Synoste's co-creation...
The national Dream Workday is coming again on 2nd October with aim to bring positive energy to the workday and to promote well-being at work. The theme of the day at Innokas is training and...
Innokas Medical and its personnel participated in the Cycling Competition (Kilometrikisa in Finnish), which was a playful contest aiming to enthuse people to cycle more. The Cycling Competition...
Through MDSAP (Medical Device Single Audit) certificate, the companies are able to indicate they operate according to ISO 13485:2016 -standard and regulatory requirements set by Australia, Brazil,...
